Biogen Idec (NASDAQ:BIIB) Director Lynn Schenk sold 1,000 shares of the company’s stock on the open market in a transaction dated Monday, December 2nd. The shares were sold at an average price of $291.71, for a total value of $291,710.00. Following the sale, the director now directly owns 3,325 shares of the company’s stock, valued […]
Biogen Idec Director Lynn Schenk Unloads 1,000 Shares (BIIB) is a post from: Zolmax
The post Biogen Idec Director Lynn Schenk Unloads 1,000 Shares (BIIB) appeared first on Zolmax.